Leadership
Hawthorne Effect Leadership
Entrepreneurs, scientists, artists, developers, healers
The Hawthorne Effect leadership team comprises many educational and professional backgrounds. But they are united in their dedication to enriching the quality, experience, diversity, and access to clinical trials for patients, providers, and sponsors.
Josh Rose
CEO
Laurie Hayner
VP, Clinical Operations
John Taylor
Chief Technology Officer
Enrique Rodriquez-Paz, MD
Medical Director
Kelly Munley
Senior Director of Quality Assurance, Regulatory Affairs and Compliance
Dani Darasz
VP, Clinical Success and Community
Bill Purdy
VP of Product Design
Hawthorne Effect Board of Directors
Our board is a group of dedicated visionaries whose values center on excellence, humanity, innovation, and the impact of our clinical trials
Jonathan DiVincenzo
President of Central Laboratories and International, Labcorp
Tony Clapsis
Founder, Arcadia Advisors and SVP, CVS Health (Former)
Lucy Coassin
Principal, Northpond Ventures
Ingo Chakravarty
Operating Partner, Northpond Ventures
Jodi Akin
Founder, Hawthorne Effect
Josh Rose
CEO, Hawthorne Effect
Hawthorne Effect Advisors
Our advisors are advocates committed to integrity, efficiency, and connection with our patients, sponsors, and Heroes
Mary Stutts
Ron Adner
Esther Dyson
Martin Leon
Discover how we can help your trial
Let’s discuss how Hawthorne Effect can take your clinical trial to completion and approval with access and accuracy